Read more information about Lareb and our research about adverse drugs reactions (ADRs)
Home
Actueel
-
11 september 2026Study Does Not Prove That Paracetamol Use During Pregnancy Harms Fertility
Current recommendationsremainunchanged: paracetamolremainsthe preferred treatment for pain and fever during pregnancy.Leaving a fever or persistent pain untreated may also carry risks f...
-
07 juli 2026Nightmares with desloratadine
Patients using desloratadine sometimesreportnightmares orabnormal dreams.Between 2014 and 2026,the Dutch Pharmacovigilance Centre Larebrecievedtwelve reports about nightmares with desloratadine. Desloratadine is a medicationindica...
-
10 november 2025Florence van Hunsel appointed as Professor of Pharmacovigilance
Dr. Florence van Hunsel, pharmacist and senior epidemiologist at the Netherlands Pharmacovigilance Centre Lareb, becomes Professor by special appointment of Pharmacovigilance at the University of ...
View reports
Enter at least the first four letters of the name of the medicine you are looking for in the first search bar. Then choose the right medicine.
If applicable, then select the correct dosage form in the second bar, such as: effervescent tablet, chewable tablet, suppository or oral solution.
What does Lareb do
-
News
Lareb shares information about adverse drug reactions (ADR’s) and other news about safe use of medicines. View all news items on our news items page. -
Teratology Information Service
The Teratology Information Service (TIS) is the knowledge centre of Lareb on safety of drugs used before and during pregnancy and during breastfeeding -
Research activities of Lareb
We continuously conduct research with questionnaires. This way, we learn more about known ADR's of medicines and vaccines and we learn to recognize these earlier.